Detalhe da pesquisa
1.
Secular Trend in GFR Decline in Non-Dialysis CKD Based on Observational Data From Standard of Care Arms of Trials.
Am J Kidney Dis
; 83(4): 435-444.e1, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37956953
2.
Glomerular and tubular effects of dapagliflozin, eplerenone and their combination in patients with chronic kidney disease: A post-hoc analysis of the ROTATE-3 study.
Diabetes Obes Metab
; 26(2): 576-582, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37926904
3.
Renin-Angiotensin-Aldosterone System: From History to Practice of a Secular Topic.
Int J Mol Sci
; 25(7)2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38612843
4.
Dipping Status, Ambulatory Blood Pressure Control, Cardiovascular Disease, and Kidney Disease Progression: A Multicenter Cohort Study of CKD.
Am J Kidney Dis
; 81(1): 15-24.e1, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35709922
5.
Sex difference in cardiovascular risk in patients with chronic kidney disease: pooled analysis of four cohort studies.
Nephrol Dial Transplant
; 2023 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36796825
6.
Risk of end-stage kidney disease in kidney transplant recipients versus patients with native chronic kidney disease: multicentre unmatched and propensity-score matched analyses.
Nephrol Dial Transplant
; 38(2): 507-516, 2023 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35278077
7.
Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and Their Combination in Patients with Chronic Kidney Disease: A Randomized Crossover Clinical Trial.
J Am Soc Nephrol
; 33(8): 1569-1580, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35440501
8.
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial.
Cardiovasc Diabetol
; 21(1): 235, 2022 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36344978
9.
Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial.
Eur Heart J
; 42(48): 4891-4901, 2021 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34423370
10.
Chronic Hyperkaliemia in Chronic Kidney Disease: An Old Concern with New Answers.
Int J Mol Sci
; 23(12)2022 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35742822
11.
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease.
Cardiovasc Diabetol
; 20(1): 145, 2021 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34271948
12.
Are all erythropoiesis-stimulating agents created equal?
Nephrol Dial Transplant
; 36(8): 1369-1377, 2021 07 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32206785
13.
Predictive effect of salt intake on patient and kidney survival in non-dialysis CKD: competing risk analysis in older versus younger patients under nephrology care.
Nephrol Dial Transplant
; 36(12): 2232-2240, 2021 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33877358
14.
Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease.
Nephrol Dial Transplant
; 36(2): 267-274, 2021 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32829405
15.
Sex difference in ambulatory blood pressure control associates with risk of ESKD and death in CKD patients receiving stable nephrology care.
Nephrol Dial Transplant
; 36(11): 2000-2007, 2021 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33693796
16.
Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A PostHoc Analysis from the CREDENCE Trial.
J Am Soc Nephrol
; 31(12): 2925-2936, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32998938
17.
Volume-Independent Sodium Toxicity in Peritoneal Dialysis: New Insights from Bench to Bed.
Int J Mol Sci
; 22(23)2021 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34884617
18.
Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies.
Am J Kidney Dis
; 75(1): 30-38, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31409508
19.
Preventing major adverse cardiovascular events by SGLT-2 inhibition in patients with type 2 diabetes: the role of kidney.
Cardiovasc Diabetol
; 19(1): 35, 2020 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32192503
20.
Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics.
Nephrol Dial Transplant
; 35(1): 138-147, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30053127